AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
Anti-cancer agents - Preface
Authors: Kozikowski, AP Baraldi, PG
Citation: Ap. Kozikowski et Pg. Baraldi, Anti-cancer agents - Preface, CUR PHARM D, 7(17), 2001, pp. NIL_2-NIL_3
Design, synthesis and biological activity of 5-fluorouracil-distamycin hybrids
Authors: Baraldi, PG Romagnoli, R Martinez, A de las Infantas, MJP Gallo, MA Espinosa, A Rutigliano, C Bianchi, N Gambari, R
Citation: Pg. Baraldi et al., Design, synthesis and biological activity of 5-fluorouracil-distamycin hybrids, MED CHEM RE, 10(6), 2001, pp. 390-403
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors
Authors: Manfredini, S Baraldi, PG Durini, E Porcu, L Angusti, A Vertuani, S Solaroli, N De Clercq, E Karlsson, A Balzarini, J
Citation: S. Manfredini et al., Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors, BIOORG MED, 11(10), 2001, pp. 1329-1332
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor ligands: A starting point for searching A(2B) adenosine receptor antagonists
Authors: Baraldi, PG Cacciari, B Romagnoli, R Klotz, KN Spalluto, G Varani, K Gessi, S Merighi, S Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor ligands: A starting point for searching A(2B) adenosine receptor antagonists, DRUG DEV R, 53(2-3), 2001, pp. 225-235
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor
Authors: Baraldi, PG Cacciari, B Romagnoli, R Spalluto, G Varani, K Cessi, S Merighi, S Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor, DRUG DEV R, 52(1-2), 2001, pp. 406-415
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines
Authors: Baraldi, PG Nasser, AZ Fruttarolo, F Tabrizi, MA Nunez, MC Spalluto, G Romagnoli, R
Citation: Pg. Baraldi et al., A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines, SYNTHESIS-S, (5), 2001, pp. 773-777
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalizedpyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies
Authors: Baraldi, PG Cacciari, B Moro, S Romagnoli, R Ji, XD Jacobson, KA Gessi, S Borea, PA Spalluto, G
Citation: Pg. Baraldi et al., Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalizedpyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies, J MED CHEM, 44(17), 2001, pp. 2735-2742
Design, synthesis, DNA binding, and biological evaluation of water-solublehybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders
Authors: Baraldi, PG Balboni, G Pavani, MG Spalluto, G Tabrizi, MA De Clercq, E Balzarini, J Bando, T Sugiyama, H Romagnoli, R
Citation: Pg. Baraldi et al., Design, synthesis, DNA binding, and biological evaluation of water-solublehybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders, J MED CHEM, 44(16), 2001, pp. 2536-2543
Pharmacological and biochemical characterization of A(3) adenosine receptors in Jurkat T cells
Authors: Gessi, S Varani, K Merighi, S Morelli, A Ferrari, D Leung, E Baraldi, PG Spalluto, G Borea, PA
Citation: S. Gessi et al., Pharmacological and biochemical characterization of A(3) adenosine receptors in Jurkat T cells, BR J PHARM, 134(1), 2001, pp. 116-126
New potent and selective human adenosine A(3) receptor antagonists
Authors: Baraldi, PG Borea, PA
Citation: Pg. Baraldi et Pa. Borea, New potent and selective human adenosine A(3) receptor antagonists, TRENDS PHAR, 21(12), 2000, pp. 456-459
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding totranscription factor Sp1
Authors: Baraldi, PG Cacciari, B Guiotto, A Romagnoli, R Spalluto, G Leoni, A Bianchi, N Feriotto, G Rutigliano, C Mischiati, C Gambari, R
Citation: Pg. Baraldi et al., [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding totranscription factor Sp1, NUCLEOS NUC, 19(8), 2000, pp. 1219-1229
Pyrazole related nucleosides 5. Synthesis and biological activity of 2 '-deoxy-2 ',3 '-dideoxy- and acyclo-analogues of 4-iodo-1-beta-D-ribofuranosyl-3-carboxymethyl pyrazole (IPCAR).
Authors: Manfredini, S Baraldi, PG Bazzanini, R Durini, E Vertuani, S Pani, A Marceddu, T Demontis, F Vargiu, L La Colla, P
Citation: S. Manfredini et al., Pyrazole related nucleosides 5. Synthesis and biological activity of 2 '-deoxy-2 ',3 '-dideoxy- and acyclo-analogues of 4-iodo-1-beta-D-ribofuranosyl-3-carboxymethyl pyrazole (IPCAR)., NUCLEOS NUC, 19(4), 2000, pp. 705-722
Anti-cancer agents - Preface
Authors: Kozikowski, AP Baraldi, PG
Citation: Ap. Kozikowski et Pg. Baraldi, Anti-cancer agents - Preface, CUR PHARM D, 6(3), 2000, pp. NIL_2-NIL_2
Anti-cancer agents - Preface
Authors: Kozikowski, AP Baraldi, PG
Citation: Ap. Kozikowski et Pg. Baraldi, Anti-cancer agents - Preface, CUR PHARM D, 6(18), 2000, pp. NIL_4-NIL_4
DNA minor groove alkylating agents structurally related to distamycin A
Authors: Baraldi, PG Spalluto, G Cacciari, B Romagnoli, R
Citation: Pg. Baraldi et al., DNA minor groove alkylating agents structurally related to distamycin A, EXPERT OP T, 10(6), 2000, pp. 891-904
CC-1065 and the duocarmycins: recent developments
Authors: Cacciari, B Romagnoli, R Baraldi, PG Da Ros, T Spalluto, G
Citation: B. Cacciari et al., CC-1065 and the duocarmycins: recent developments, EXPERT OP T, 10(12), 2000, pp. 1853-1871
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor
Authors: Baraldi, PG Romagnoli, R Tabrizi, MA Falzoni, S Di Virgilio, F
Citation: Pg. Baraldi et al., Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor, BIOORG MED, 10(7), 2000, pp. 681-684
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: thefirst high affinity radioligand antagonist for the human A(3) adenosine receptors
Authors: Baraldi, PG Cacciari, B Romagnoli, R Varani, K Merighi, S Gessi, S Borea, PA Leung, E Hickey, SL Spalluto, G
Citation: Pg. Baraldi et al., Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: thefirst high affinity radioligand antagonist for the human A(3) adenosine receptors, BIOORG MED, 10(3), 2000, pp. 209-211
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A(1)-adenosine receptor
Authors: Baraldi, PG Zaid, AN Lampronti, I Fruttarolo, F Pavani, MG Tabrizi, MA Shryock, JC Leung, E Romagnoli, R
Citation: Pg. Baraldi et al., Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A(1)-adenosine receptor, BIOORG MED, 10(17), 2000, pp. 1953-1957
Synthesis of hybrid distamycin-cysteine labeled with Tc-99m: a model for anovel class of cancer imaging agents
Authors: Baraldi, PG Romagnoli, R Duatti, A Bolzati, C Piffanelli, A Bianchi, N Mischiati, C Gambari, R
Citation: Pg. Baraldi et al., Synthesis of hybrid distamycin-cysteine labeled with Tc-99m: a model for anovel class of cancer imaging agents, BIOORG MED, 10(12), 2000, pp. 1397-1400
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: thefirst high affinity radioligand antagonist for the human A(3) adenosine receptors (vol 10, pg 209, 2000)
Authors: Baraldi, PG Cacciari, B Romagnoli, R Varani, K Merighi, S Gessi, S Borea, PA Leung, E Hickey, SL Spalluto, G
Citation: Pg. Baraldi et al., Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: thefirst high affinity radioligand antagonist for the human A(3) adenosine receptors (vol 10, pg 209, 2000), BIOORG MED, 10(12), 2000, pp. 1403-1403
A(3) adenosine receptor ligands: History and perspectives
Authors: Baraldi, PG Cacciari, B Romagnoli, R Merighi, S Varani, K Borea, PA Spalluto, G
Citation: Pg. Baraldi et al., A(3) adenosine receptor ligands: History and perspectives, MED RES REV, 20(2), 2000, pp. 103-128
A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles
Authors: Baraldi, PG de las Infantas, MJP Manfredini, S Romagnoli, R
Citation: Pg. Baraldi et al., A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles, SYNTHESIS-S, (1), 2000, pp. 72-74
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors
Authors: Varani, K Merighi, S Gessi, S Klotz, KN Leung, E Baraldi, PG Cacciari, B Romagnoli, R Spalluto, G Borea, PA
Citation: K. Varani et al., [H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, MOLEC PHARM, 57(5), 2000, pp. 968-975
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: Influence of thechain at the N-8 pyrazole nitrogen
Authors: Baraldi, PG Cacciari, B Romagnoli, R Spalluto, G Moro, S Klotz, KN Leung, E Varani, K Gessi, S Merighi, S Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: Influence of thechain at the N-8 pyrazole nitrogen, J MED CHEM, 43(25), 2000, pp. 4768-4780
Risultati: 1-25 | 26-45